Statins for Graves' orbitopathy (STAGO): a phase 2, open-label, adaptive, single centre, randomised clinical trial - The Lancet Diabetes & Endocrinology

Frontiers Effects of Non-statin Lipid-Modifying Agents on

PDF) Management of Thyroid Eye Disease: A Consensus Statement by

Statins for Graves' orbitopathy: a new tool for prevention and

Long-term statins administration exacerbates diabetic nephropathy

Cholesterol Serum Levels and Use of Statins in Graves' Orbitopathy

Simvastatin downregulates adipogenesis in 3T3-L1 preadipocytes and

Current concepts regarding Graves' orbitopathy - Bartalena - 2022

Statins for Graves' orbitopathy (STAGO): a phase 2, open-label

Current concepts regarding Graves' orbitopathy - Bartalena - 2022

Statins for Graves' orbitopathy (STAGO): a phase 2, open-label

Management of Thyroid Eye Disease: A Consensus Statement by the

Graves Disease: Practice Essentials, Pathophysiology, Epidemiology

Effect of dapagliflozin on the rate of decline in kidney function

Statins for primary prevention of cardiovascular events and

Lancet子刊：万能药他汀又来了，甲亢突眼它也能治！@MedSci